image4

Charles A. Sanders, M.D.

Chairman

introimage

Maria C.
Freire, Ph.D.

President and executive director

Letter from the Chairman and President

Open post

The power of our
organizational structure.
The Foundation for the National Institutes of Health (FNIH) was founded in 1996 by an act of Congress as a 501(c)(3) not-for-profit that can raise private funds in support of the NIH mission. In addition to raising funds—more than $830 million since our founding—the FNIH has excelled at creating innovative cross-sector partnerships in a neutral, pre-competitive environment to tackle large biomedical challenges with great urgency and efficiency. These partnerships offer a new way of generating the discoveries that improve health and change people’s lives for the better. For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards and performs as well or better than most charities.

Since its establishment nearly two decades ago, the Foundation for the National Institutes of Health (FNIH) has become a leader in forging powerful public-private partnerships that advance biomedical science. With the careful crafting and execution of cutting-edge initiatives, such as the Grand Challenges in Global Health and the Accelerating Medicines Partnership, the FNIH helps the National Institutes of Health (NIH) turn discovery into improved health.

As with many sectors, the need for collaboration in biomedical research is a necessity and requires expertise and years of experience. Many partnerships fail due to an inability to identify the right people, meet expectations and guide the team to measurable results. This leads to missed opportunities for groundbreaking contributions to science.

The FNIH is a proven catalyst for meaningful collaboration that produces results. To begin, the FNIH convenes the right people to develop solutions to a variety of health-related problems. The FNIH draws upon expertise from academia, industry, federal agencies and not-for-profit organizations to address problems together, rather than working individually.

Facilitating collaboration with proven, flexible management and funding models that promote innovation, the FNIH fosters consensus and leads large-scale projects that succeed with transformative results. For example, the Biomarkers Consortium’s I SPY-2 project created a new landscape for clinical trials, using precision medicine to allow multiple breast cancer treatments to be tested at the same time in a single trial. It also introduced new adaptive designs to cancer trials and helped establish an accelerated approval pathway for new breast cancer medicines. Many FNIH programs have shown that these results are greater than what could be achieved by one organization and are meaningful for the entire biomedical community.

The FNIH’s success has resulted in a robust programmatic portfolio. As evidenced in this report, the portfolio includes work to identify predictive biomarkers that correlate with knee osteoarthritis progression and better inform treatments, to support clinical research to prevent age-related cognitive decline and to build the infrastructure needed in Mali to further bioinformatics research. Additionally, the FNIH continues work to raise funds for training the next generation of young scientists and to provide free lodging for NIH Clinical Center patients and their families through the Edmond J. Safra Family Lodge.

The future of biomedical innovation relies upon a collaborative approach to tackle the world’s most pressing health challenges. Looking ahead, the FNIH is well-positioned to continue building these essential partnerships that may lead to scientific breakthroughs and improve public health for generations to come.

untitledCharles A. Sanders, M.D.
Chairman
mariaMaria C. Freire, Ph.D.
President and executive director

FNIH
At-a-Glance

  • Creating and Managing a Diverse Portfolio of Initiatives
  • Developing Diverse and Uncommon Collaborations
Open post
OUR PARTNERSHIPS

Everything we do depends on collaboration. The partnerships we forge provide funding support as well as expertise and resources to help us accomplish and expand our work. What we achieve collectively is far greater than that of any single organization.

fnih-graph

WHAT WE DO

The FNIH stands at the center of a broad portfolio of initiatives focused on shared goals: supporting the mission of the NIH and advancing biomedical science to improve lives. One of the most important functions the FNIH has is fundraising—without the ongoing support of our contributors, these initiatives would not be possible.

RESEARCH PARTNERSHIPS — We develop collaborations with top experts from government, industry, academia and the not-for-profit sector and provide
a neutral environment where we can work productively toward a common goal.
Examples include:

  • Portfolio Supporting NIH Research — Supporting and raising funds for multiple projects initiated by the NIH, while also convening the right partners within and outside of the NIH.
  • Global Health — Coordinating and operating 17 collaborative projects in 25 countries.
  • Biomarkers Consortium — Initiating and managing more than 20 projects funded with more than $50 million in private dollars, designed to develop and validate biological markers to support new drug development and patient care.

SYMPOSIA, EVENTS & EXHIBITS — We organize and facilitate more than 50 events each year, creating a forum for innovative thinkers in biomedical sciences to share ideas and engage the public in disease and health awareness.

FELLOWSHIPS & AWARDS — We provide funding for training for early-career scientists, along with support and recognition for researchers whose findings have advanced biomedical science.

PATIENT SUPPORT  — The FNIH helps support patient care activities and amenities that provide comfort and assistance to patients and their loved ones being treated at the NIH Clinical Center. For example, since its opening in 2005, the Edmond J. Safra Family Lodge has hosted more than 100,000 room nights for patients of the NIH Clinical Center and their families.

2015
Highlights

  • The Power of Collaboration
  • The Power of Innovative Models
  • The Power of Support
  • Supporting Patients and Education
Open post

CREATING A NEXUS BETWEEN DISCOVERY AND COLLABORATION. Making the discoveries that advance human health is not simply a matter of bringing together the best minds from government, industry, academia and not-for-profits. It is also about knowing how to help those organizations collaborate in ways that harness their full power and potential. The FNIH excels at creating and then leading the processes that drive complex research projects forward. Whether we are working on a long-time health challenge or an emerging threat, we guide collaborations to achieve groundbreaking results that spur action, ultimately improving human health. 

The Power of Collaboration:
Accelerating the Quest for Critical Data

img01

Finding better markers of osteoarthritis
onset and progression

Osteoarthritis develops over time as a joint’s “cushion” of cartilage breaks down and bone ends rub together, causing pain and loss of function. Knee osteoarthritis (OA) is the leading cause of disability in older adults and affects about 250 million people worldwide. Right now, OA is diagnosed only after people have discomfort, and the standard tool is an X-ray showing joint space narrowing. But the disease process begins long before symptoms appear; identifying those at risk and intervening earlier could help avoid costly joint replacements.

Earlier diagnosis may soon be possible thanks to the Osteoarthritis Biomarkers Project, a $3.4 million study led by the FNIH Biomarkers Consortium in partnership with the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the U.S. Food and Drug Administration (FDA), universities and pharmaceutical companies to identify biomarkers (biological markers) of knee OA onset and progression. Using data from 5,000 high-risk patients gathered through the National Institutes of Health Osteoarthritis Initiative, another public-private partnership that created an open-access repository of medical images and blood and urine samples, the FNIH-led team has narrowed thousands of potential biomarkers down to a subset that correlates with knee OA progression. These include bone and cartilage changes visible on MRI and proteins detectable in blood and urine. The biomarkers can pave the way toward identifying people at risk and developing treatments that target the disease process.

[OSTEOARTHRITIS PARTNERS]

[ close ]

OSTEOARTHRITIS PARTNERS

AbbVie

Amgen

Arthritis Foundation

BIOIBERICA S.A.

DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc.

U.S. Food and Drug Administration, Center for Devices and Radiologic Health

Flexion Therapeutics, Inc.

GlaxoSmithKline

Merck Serono

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Rottapharm | Madaus

Sanofi

Identifying new targets to drive
drug development

Launched in 2014, the Accelerating Medicines Partnership (AMP) is a five-year, $230 million effort joining the resources of the FNIH, the National Institutes of Health (NIH) and the FDA with those of several nonprofit organizations and biopharmaceutical companies to devise a more precise approach to early-stage drug development. These organizations are sharing expertise and data to identify the biological pathways underlying four devastating diseases—type 2 diabetes (T2D), rheumatoid arthritis/systemic lupus erythmatosus (RA/SLE) and Alzheimer’s disease (AD)—and then validate the best candidates for targeting new medicines. AMP’s vision is to empower researchers to pursue new treatments with better odds of moving through the clinical trials pipeline successfully. Current therapies for these conditions cannot reverse the disease process nor stop its progression.

In 2015, the AMP-T2D Project publicly launched a knowledge portal that has amassed large amounts of genetic and clinical data from an array of studies on people with type 2 diabetes. The portal’s data cover a wide variety of ethnicities, including African-American, East Asian, South Asian, European and Hispanic, as well as diabetes-related cardiovascular and kidney complications. Researchers will be able to search and analyze the data to identify genetic variants associated with increased risk for, or protection against, the development of diabetes and its complications. In turn, these can become potential targets for new treatments.

image3
The AMP-RA/SLE Project has developed new methods for acquiring and processing tissue from the kidneys and synovial membranes (linings of joints) and trained researchers to use these methods, making multi-site clinical studies possible. This tissue, along with blood and urine samples, is being utilized to generate a new public data repository to be launched in 2016. For the first time, partner organizations will be able to collaborate on genome-wide analysis of these samples to better understand the mechanisms behind the destruction caused by rheumatoid arthritis and systemic lupus erythmatosus, both diseases in which the body’s immune system destroys healthy tissue.

AMP-AD includes two different projects. Project A seeks to validate existing biomarkers as possible indicators of response to treatment in people with Alzheimer’s disease. Just one example is PET imaging of tau proteins in the brain, which has been added to two major NIH-funded phase II/III drug trials. Project B is working to accelerate the discovery of new therapeutic targets, moving beyond the traditional focus on the buildup of proteins such as amyloid and tau in brain tissue. Researchers build a deeper understanding of the networks in which these novel targets operate and validate them in different models. The project integrates analysis of large-scale molecular data from more than 2,000 human brains at all stages of the disease with network modeling approaches and experimental validation. This project has created a knowledge portal that enables rapid, broad sharing of data and analytical tools, and periodically releases public waves of large-scale molecular data from human brain samples. The ultimate goal is to shorten the time between discovery of potential drug targets to development of new drugs for Alzheimer’s treatment and prevention.

[AMP PARTNERS]

[ close ]

AMP PARTNERS

DIABETES:

American Diabetes Association

Eli Lilly and Company

Janssen Research & Development, LLC

JDRF International

Merck & Co., Inc.

Pfizer Inc

Sanofi

RA/SLE:

AbbVie

Alliance for Lupus Research

Arthritis Foundation

Bristol-Myers Squibb Company

The Lupus Foundation of America

Merck & Co., Inc.

Pfizer Inc

Rheumatology Research Foundation

Sanofi

Takeda Pharmaceuticals

ALZHEIMER’S DISEASE:

AbbVie

Alzheimer’s Association®

Alzheimer’s Drug Discovery Foundation

Biogen

Geoffrey Beene Foundation Alzheimer’s Initiative

GlaxoSmithKline

Janssen Research & Development, LLC

Eli Lilly and Company

Vradenburg Foundation

The Power of Innovative Models:
Reframing Approaches to Longstanding Challenges

a

Identifying biomarkers in children to help
advance autism research

An average of one in every 68 eight-year-old children in the United States is diagnosed with Autism Spectrum Disorder (ASD), typically based on behavioral observations by parents and caregivers—but these behaviors can range widely. Developing effective interventions and treatments through clinical trials depends on developing more sensitive and objective standards for diagnosing ASD in children and evaluating change over time.

In 2015, the FNIH partnered with the National Institute of Mental Health, Simons Foundation Autism Research Initiative (SFARI), FDA, Janssen Research & Development, LLC and European Autism Interventions – A Multicentre Study for Developing New Medications (EU-AIMS) to support a study of preschool and school-aged children with ASD to validate biomarkers that could help assess social function, track changes in behavior and neurologic function, and potentially evaluate the effectiveness of pharmacologic treatments. The FNIH is managing a $2 million contribution from SFARI to fund the Yale University study led by James McPartland, Ph.D., Principal Investigator, which is collecting data from children at five sites nationwide using assessments of social impairment, such as clinician, caregiver and lab-based tools; neurophysiological measures, such as eye tracking and studies of brain activity (EEG, or electroencephalogram); and blood samples from participants and their parents for genetic analysis. This $28 million large-scale U.S. partnership to identify biomarkers associated with ASD is part of the FNIH Biomarkers Consortium.

[AUTISM PARTNERS]

[ close ]

AUTISM PARTNERS

Eunice Kennedy Shriver National Institute of Child Health and Human Development

European Autism Interventions — A Multicentre Study for Developing New Medications (EU-AIMS)

Janssen Research & Development, LLC

National Institute of Mental Health

National Institute of Neurological Disorders and Stroke

Simons Foundation

Autism Research Initiative

U.S. Food and Drug Administration

b

Building research
infrastructure in Africa

To develop the new vaccines and treatments that improve public health, researchers require access to high-performance computing resources for collecting and analyzing complex biological data. Many low-income countries lack the infrastructure needed for bioinformatics research, even as they face some of the world’s most challenging and often-neglected diseases.

Last year, the FNIH played a pivotal role in helping the National Institute of Allergy and Infectious Diseases (NIAID) launch the first African Center of Excellence in Bioinformatics (ACE) in Mali, West Africa. Building on NIAID’s ongoing support for researchers in Mali, the FNIH invited corporate partners such as The BioTeam Inc., Intel Corporation Health and Life Sciences Group, the EMC Corporation and Hewlett Packard Enterprise to donate equipment for computing and data analysis, high-speed connectivity, and research and classroom spaces. Mali ACE opened in April 2015 at the University of Sciences, Techniques and Technology of Bamako (USTTB). Local researchers are now able to conduct advanced bioinformatics research while receiving long-distance training and mentorship by NIAID researchers. Mali ACE will serve as a model for future bioinformatics research centers in other regions of Africa.

[ACE PARTNERS]

[ close ]

ACE PARTNERS

The BioTeam Inc.

EMC Corporation

Hewlett Packard Enterprise

Intel Corporation Health and Life Sciences Group

National Institute of Allergy and Infectious Diseases

University of Sciences, Techniques, and Technology of Bamako, Mali, West Africa

c

Continuing in the search for
an HIV vaccine

Since the mid-1990s, the successful development of medications for people with human immunodeficiency virus, or HIV, has deflected some attention from the search for a preventive vaccine. But no medicine has cured HIV, and only about half of the more than 33 million HIV-positive people worldwide can access treatment. A successful vaccine is still considered fundamental for conquering HIV/AIDS.

For nearly 10 years, the FNIH has served as coordinator for the Comprehensive
T Cell Vaccine Immune Monitoring Consortium (CTVIMC), a central service facility within the Collaboration for AIDS Vaccine Discovery supported by the Bill & Melinda Gates Foundation. With more than $50 million in funding and researchers at multiple universities, as well as the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, the CTVIMC is looking at how candidate HIV vaccines trigger a response from the body’s immune system “defenders,” including T cells and B cells and the antibodies they activate. The FNIH’s role is to ensure that all of the researchers have access to a standardized set of T cell and B cell assays—including materials, techniques, measurements and reporting—so that results can be shared meaningfully across all sites. CTVIMC represents just one slice of the work going on within the Collaboration for AIDS Vaccine Discovery, which involves more than 600 investigators across 87 institutions in 12 countries.

[CTVIMC PARTNERS]

[ close ]

CTVIMC PARTNERS

Becton, Dickinson and Company

Beth Israel Deaconess Medical Center

Biomedical Primate Research Centre

Case Western Reserve University

Centre hospitalier universitaire vaudois

Duke University

Fred Hutchinson Cancer Research Center

Henry M. Jackson Foundation

Imperial College London

International AIDS

Vaccine Initiative

McMaster University

National Institute of Allergy and Infectious Diseases

National Institute of Health and Medical Research (INSERM, France)

SeraCare Life Sciences

University of Montreal

University of Oxford

University of Washington

Vaccine & Gene Therapy Institute Florida

Wits Health Consortium

The Power of Support:
Channeling Resources for Greatest Impact

d

Recognizing groundbreaking work by
early-career scientists

Due to steady declines in financial support for basic science research, today’s young scientists face a challenging environment in which tenure-track university positions are scarce and about 85 percent of research grant proposals are unfunded. It is not unusual for biomedical researchers to reach their late 30s or 40s before receiving a major research grant—and this affects their ability to make significant, career-changing discoveries.

Three years ago, the FNIH established the Lurie Prize in Biomedical Sciences, named for philanthropist and Board member Ann Lurie, to help propel the work of one truly stellar, early-career researcher each year. The prestigious prize, which includes a medal and significant research honorarium, is awarded at a Washington, DC ceremony every spring. The 2015 Lurie Prize winner was Howard Hughes Medical Institute Investigator and Stanford University neuroscientist and psychiatrist Karl Deisseroth, M.D., Ph.D., who along with his team has pioneered two game-changing techniques: optogenetics, which uses light to map the neural circuits in our brains, and a technology called CLARITY that allows scientists to make organs transparent and therefore easier to study under a microscope. In his hands, both promise to revolutionize our approach to neurological diseases such as major depression, Alzheimer’s and Parkinson’s.

—(l to r) Solomon H. Snyder, M.D., Chairman, Lurie Prize Jury and FNIH Board Vice Chairman for Science; Ann Lurie, Lurie Prize Honorary Chair and FNIH Board Member; Karl Deisseroth, M.D., Ph.D., 2014 Lurie Prize Recipient; Maria C. Freire, Ph.D., FNIH President and Executive Director; Francis S. Collins, M.D., Ph.D., NIH Director and FNIH Board Ex Officio Member

e

Investigating the genetics of age-related eye disease

In 2001, researchers with the National Eye Institute’s Age-Related Eye Disease Study (AREDS) reported that a nutritional supplement called the “AREDS formulation”—including high doses of vitamin C, vitamin E, beta-carotene, zinc and copper—can reduce the risk of developing advanced age-related macular degeneration (AMD), the leading cause of vision loss and blindness for Americans over 65. A follow-up study called AREDS2 enrolled more than 4,200 people with AMD and found that replacing beta-carotene in the AREDS formulation with lutein and zeaxanthin provided an incremental beneficial effect and reduced the risk of lung cancer, especially in former and current smokers. Those results were published in 2013. Preventing the progression of AMD is critical since there are no effective treatment options for advanced AMD.

Thanks in part to support from the FNIH, the impact of the AREDS2 study will not end there. The FNIH provided funding to create the AREDS2 Genetic Repository, a collection of blood and saliva samples from AREDS2 participants. Genomic analysis is now under way, with the goal of understanding how a person’s genes play a role in the progression of vision-threatening AMD. Several genetic variants were already identified in a December 2015 Nature Genetics article. The repository is an important new tool for all researchers studying the genetics of AMD.

[AREDS PARTNERS]

[ close ]

AREDS PARTNERS

Alcon Research Ltd.

Bausch & Lomb

Genentech

National Eye Institute

f

Preventing cognitive decline

Age-related decline in cognitive function is real and varies widely among individuals, influencing quality of life, character of personal relationships and capacity for making informed decisions about health care, retirement and other issues faced daily by millions of older adults.

In 2007, the McKnight Brain Research Foundation (MBRF) partnered with the FNIH and the National Institute on Aging (NIA) to fund the first Cognitive Aging Summit, where dozens of researchers shared ideas about how best to understand and remediate age-related cognitive decline. The Summit led to the Research Partnership in Cognitive Aging in 2008, a public-private effort between the NIA and the MBRF. Beginning in 2009, the partnership funded two research initiatives, 17 grants totaling $28 million over five years. The partnership supported a second Summit in 2010, with recommendations leading to a third joint initiative focused on interventions.

In 2014, the partnership, along with the National Center for Complementary & Integrative Health and the NIH Office of Behavioral and Social Sciences Research, funded the $15 million MEDEX (Mindfulness, Health Education, & Exercise) trial. Now underway, the trial is comparing the effectiveness of mindfulness-based stress reduction, brain health education and aerobic exercise as strategies for improving cognitive function.

[COGNITIVE AGING PARTNERS]

[ close ]

COGNITIVE AGING PARTNERS

McKnight Brain Research Foundation

National Center for Complementary and Integrative Health

National Institute on Aging

NIH Office of Behavioral and Social Sciences Research

Supporting Patients and Education

 

EDMOND J. SAFRA FAMILY LODGE: TEN YEARS OF CARING

On November 5, 2015, the FNIH welcomed Board member and guest of honor Mrs. Lily Safra to celebrate the 10th anniversary of the Edmond J. Safra Family Lodge, which since 2005 has hosted more than 100,000 room nights for patients of the NIH Clinical Center and their families. The Family Lodge provides a home-like setting free of charge for guests from across the nation and around the world. This service exists thanks to the generosity of the Edmond J. Safra Philanthropic Foundation and many other individual donors, corporations and foundations. Mrs. Lily Safra donated proceeds from her Jewels for Hope auction to support
the preservation of the Family Lodge according to her vision.

— Mrs. Lily Safra (center) with the Family Lodge staff at the 10th Anniversary Open House Celebration

A GRATEFUL PATIENT’S PRAISE FOR RESEARCH

“As an engineer with a healthy dose of curiosity, the process of searching for answers has always interested me. I have been at the NIH on a daily basis for almost three months and have not only observed my caregivers taking copious notes based on what I’m experiencing, but also overheard post-doctoral interns talking to their advisors in the cafeteria, noticed the topics of numerous and daily seminars being displayed on the atrium monitors and developed a clear sense for everyone’s focus here. They are all searching for what they don’t know, challenging the norm and looking for answers in areas of human suffering that until even recently seemed completely mysterious, or at least decades away from any reliable solutions.”

“This constant drive, the never-ending curiosity to search and to search again and again—this is research! It is the bedrock of this amazing and unique institution. We need to make sure the curiosity and the drive to seek solutions never abate due to a lack of funding or worse, apathy.”

— Romit Bhattacharya of Morris Plains, New Jersey, who at the urging of family and friends, traveled 260 miles to the NIH during the summer of 2015 to receive treatment for stage III lung cancer as part of a clinical trial. The FNIH fondly remembers Mr. Bhattacharya, who passed away in March 2016

MEDICATION DONATIONS HELP REDIRECT FUNDS TO RESEARCH

Since 2009, Sanofi Foundation for North America and Novartis Pharmaceuticals Corporation have donated more than $6.4 million in medications to the NIH Clinical Center through the FNIH’s In-Kind Drug Donation Program, freeing up critical dollars for research. The center is the nation’s largest hospital entirely devoted to clinical research, and patients receive all care free of charge.

SUPPORT FOR A NEW GENERATION OF RESEARCH SCIENTISTS

In fall 2015, two young scholars at the NIH were awarded full funding for their first year of education and training, thanks to a generous gift to the FNIH by the Jayne Koskinas Ted Giovanis (JKTG) Foundation for Health and Policy.

Jose Delgado-Jimenez received an NIH Postbaccalaureate Intramural Research Training Award/Cancer Research Training Award (Postbac IRTA/CRTA), which offers recent college graduates who plan to apply to graduate or health professional school the opportunity to spend one or two years performing full-time research at the NIH. Jose has a special interest in nanotechnology and cancer therapeutics. The JKTG Foundation gift also supported a scholarship to NIH’s Graduate Partnership Program (GPP), which brings Ph.D. students to the NIH Intramural Research Program for dissertation research. Awardee Ryan Phillips’ research interests include mathematical/molecular modeling and brain circuitry.

Both students are working side-by-side with some of the leading scientists in the world and experiencing the collaborative, interdisciplinary research environment that NIH has to offer.

— (l to r) Ted Giovanis, FHFMA, MBA, President and Founder JKTG Foundation for Health and Policy; Jose Delgado-Jimenez; J. Graham Atkinson, D.Phil., JKTG Foundation, Exec. VP for Research and Policy; Martin Brechbiel, Ph.D., Section Chief Radiation Oncology Branch at the National Cancer Institute (Jose’s mentor)

 

MORE FELLOWSHIPS FOR KIDNEY CANCER RESEARCH

October 4, 2015, marked the 10th anniversary of the Boo! Run for Life event in Washington, DC to benefit the Dean R. O’Neill Renal Cell Cancer Fund. This fund, together with the Dr. Edward T. Rancic Memorial Cancer Research Fund, supports a rotation of full-time fellows in the laboratory of Dr. Richard Childs of the National Heart, Lung and Blood Institute, where they focus on developing novel therapies for advanced kidney cancer.

— Pictured: Jennifer Melis of
Washington, DC

NEW FUNDING, NEW CAREER PATHWAYS

Two major grants through the FNIH are helping the NIH create new career-building opportunities for aspiring researchers. Thanks to an $850,000 grant from the Amgen Foundation, the NIH is now one of a select group of higher learning institutions taking part in the Amgen Scholars Program, which provides hundreds of summer research opportunities to undergraduate students. A $200,000 gift from the Congress of Neurological Surgeons (CNS) has created the NINDS/CNS Getch Scholar Award in collaboration with the National Institute of Neurological Disorders and Stroke (NINDS). This competitive award will provide two years of funding to help an early-career neurosurgeon launch a clinical and research career at a U.S. academic medical center.

— 2015 NIH scholars of the Amgen
Scholars Program

LAUNCHING WOMEN INTO RESEARCH CAREERS

In 2015, the Sallie Rosen Kaplan Postdoctoral Fellowship for Women Scientists in Cancer Research (SRK) Program welcomed 10 outstanding post-doctoral National Cancer Institute researchers—all female and some from underrepresented minority groups—to participate in leadership workshops and seminars, receive mentoring and coaching and develop a peer network. The program is designed to help with their transition to independent research careers.

—Pictured left to right: Elizabeth Spehalski, Rachel Van Duyne, Leah Randles, Mariia Novikova, Clara Bodelon, Khadijah Mitchell, Tiffany Lyle, Elizabeth Yanik, Pamela Gallagher, Maeve Mullooly

HUMAN GENOME EXHIBIT ON TOUR

Three million Smithsonian visitors toured Genome: Unlocking Life’s Code from June 2013 to August 2014 at the National Museum of Natural History, an exhibition made possible through funds raised, in part, by the FNIH. The result of a collaboration between the museum and the National Human Genome Research Institute, Genome showcased the complexity and power of the human genome using 3-D models, interactive displays, custom animations and real-life stories. The exhibit is now on a five-year tour to museums and science centers across North America.

—2015 HOST CITIES:
Portland, Saint Louis, San Diego
and San Jose

—2016 HOST CITIES:
Milwaukee (Jan. 23–April 25),
Salt Lake City (May 21–Sept. 5) and Wichita (Sept. 30 – Jan. 1, 2017)

 

Financial Highlights

Open post

2015 Revenues by source

57.2%
Foundations

34.8%
Corporations

3.5%
Individuals

2.9%
Government

1.6%
Non-for-Profit

2015 Donors by type

87.6%
Individuals

7.3%
Corporations

2.6%
Fundations

2.4%
Non-for-Profit

0.1%
Government

2015 EXPENSES

89%
Research Partnerships

7%
Management and Fundraising

4%
Education and Events

For the years ended December 31, 2015 and 2014
TOTAL REVENUE AND SUPPORT $34,505,611  $76,561,089
REVENUE AND SUPPORT 2015 2014
Contributions  $31,609,545 $72,770,911
Grants 663,972  634,635
Administrative fee 194,500 197,177
Government appropriations 1,000,000  500,000
Investment earnings (204,884) 206,479
In-kind contributions 874,517  1,724,619
Donated services 110,811 188,637
Fundraising event 257,150 184,675
Other revenue —  153,956

EXPENSES AND CHANGES IN NET ASSETS

TOTAL PROGRAM SERVICES $55,435,701 $71,931,053
PROGRAM SERVICES
Fellowships and training programs $1,210,274 $1,605,067
Memorials, awards and events  734,852  442,058
Capital projects 313,270 103,421
Research partnerships 53,177,305 69,780,507
TOTAL SUPPORTING SERVICES $4,163,743 $4,199,073
SUPPORTING SERVICES
Management and general $3,781,357 $3,928,920
Fundraising 382,386 270,153
TOTAL EXPENSES  $59,599,444  $76,130,126
CHANGE IN NET ASSETS  $(25,093,833)  $430,963
NET ASSETS BEGINNING OF YEAR $91,569,381 $91,138,418
NET ASSETS AT END OF YEAR $66,475,548 $91,569,381 
The Foundation's audited financial statements are available on request.

Contributors

Open post
Giving to the FNIH

We are grateful to the many individuals and organizations that have established funds and endowments, paid tribute to loved ones or joined one of our giving societies. arlingonors are nalcognized in a variety of ways and some societies include membership benefits. Please follow the links below to learn more about these giving opportunities as published on our website.l

ANNUAL CONTRIBUTIONS — Join the Partners for Innovation, Discovery and Health Society at: fnih.org/PartnersSociety

PLANNED GIVING — Do you have questions regarding bequests or transferring stock?
Visit our planned giving website at: fnih.org/PlannedGiving and join other donors who have included the FNIH in their estate plans at: fnih.org/LegacySociety

TRIBUTE GIVING — Such gifts are made to honor or memorialize a loved one. Learn more: fnih.org/TributeGiving

FUNDS AND ENDOWMENTS — To establish a fund or endowment that advances research at the NIH or the FNIH in a particular area of interest to you, search the listings of current FNIH programs by visiting: fnih.org/Programs

Please call 301.402.4976 or email advancement@fnih.org if you have any questions.

Our Donors

All FNIH donors play a critical role in providing the resources that are vital to our success. Unrestricted gifts allow us the flexibility to use them where they are most needed, from supporting core operations to developing new partnerships and emerging program ideas. Donors also can choose to restrict their gifts to an area of interest, such as a biomedical research program; a fellowship, lecture or symposium that trains scientists and helps them build their careers; or a specific laboratory or area of scientific research at the NIH.

We are grateful to the many individuals and organizations who made donations, gifts and pledges in 2015. Every attempt is made to list donors according to their wishes. Please call 301.402.4976 if you have any questions.

OF EVERY DOLLAR SPENT, 93 CENTS
ARE USED TO SUPPORT PROGRAMS
AND JUST SEVEN CENTS FOR
ADMINISTRATION AND FUNDRAISING.

charity-nav

For 11 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards and performs as well or better than most charities.

$250,000–$5,000,000+

$5,000,000+

Anheuser-Busch InBev

Bill & Melinda Gates Foundation 14

$2,500,000–$4,999,999

AbbVie Inc. 2

Johnson & Johnson 15

Eli Lilly and Company 9

National Football League 2

Wyeth Nutrition

[x] Superscript indicates number of years of consecutive giving.
* Indicates Gifts in Kind.
∞ Member of the Partners for Innovation, Discovery and Health Society

$1,000,000 – $2,499,999

Amgen, Inc. 13

Laura and John Arnold Foundation

Biogen 5

Bristol-Myers Squibb Company 16

Clinical Research Associates, LLC,
an affiliate of the Simons Foundation

GlaxoSmithKline 17

McKnight Brain Research Foundation 10

Merck Sharp & Dohme Corp. 18

National Institutes of Health 20

Pfizer Inc 18

$500,000 – $999,999

Sanofi* 14

Takeda Pharmaceuticals International, Inc. 7

$250,000 – $499,999

Arthritis Foundation 6

AstraZeneca Pharmaceuticals, LP 14

Daiichi Sankyo, Inc. 6

Fubon Financial Holding
Venture Capital Corporation

Genentech, Inc. 9

Robert Wood Johnson Foundation

Regeneron Pharmaceuticals, Inc. 3

$50,000–$249,999

$100,000 – $249,999

AgNovos Healthcare

Astellas Pharma Inc. 2

Bioiberica S.A. 2

Buffy Cafritz 12 ∞

Congress of Neurological Surgeons

Doris Duke Charitable Foundation 2

The Jayne Koskinas Ted Giovanis Foundation
for Health and Policy

Healthcare Information and Management Systems Society 4

Institut de recherches Internationales Servier
and ADIR

[x] Superscript indicates number of years of consecutive giving.
* Indicates Gifts in Kind.
∞ Member of the Partners for Innovation, Discovery and Health Society

Ann Lurie 4

Mr. and Mrs. Joel S. Marcus 5 ∞

Martin J. Murphy, Ph.D. and Ann Murphy, Ph.D. 10
In honor of Dr. and Mrs. Charles A. Sanders

National Dairy Council 5

The Pew Charitable Trusts 2

Pharmaceutical Research and
Manufacturers of America 11

Piramal Imaging SA 5

Roche 8

Estate of Eugene Woolf and Dismas S. Blanco

$50,000 – $99,999

Abbott 8

American Association for Dental Research 3

Bayer HealthCare Pharmaceuticals Inc. 3

Howard Hughes Medical Institute 4

JSI Research & Training Institute, Inc. 2

The Medicines Company 2

Novartis Pharmaceuticals Corporation 16

PhRMA Foundation 8

Charles A. Sanders, M.D.
and Ann E. Sanders 19

Siemens Corporation

$5,000–$49,999

$25,000 – $49,999

American Society for
Bone and Mineral Research 3

The Geoffrey Beene Foundation
Alzheimer’s Initiative 3

Biotechnology Innovation Organization 8

Boehringer Ingelheim Pharmaceuticals, Inc.* 7

Colgate-Palmolive Company 3

Forest Laboratories, Inc.

IXICO Ltd. 4

Peter and Judy Kovler 2

Meso Scale Diagnostics, LLC. 7

Mr. and Mrs. Paul M. Montrone 18 ∞

NeuroRx 4

Rheumatology Research Foundation 2

BioClinica, Inc. 6

George and Trish Vradenburg,
Co-Founders USAgainst Alzheimer’s 4

$10,000–$24,999

Anonymous (2)

Janet B. Abrams 7
In memory of Bernard W. Abrams

Achaogen, Inc.

John and Sandra Atkins

John K. and Sarah Bartosz

BioClinica, Inc. 6

CHDI Foundation

The Geaton & JoAnn DeCesaris
Family Foundation, Inc.

James H. and
Christina W. Donovan 4

The Epsilon Group

EUROIMMUN AG 2

[x] Superscript indicates number of years of consecutive giving.
* Indicates Gifts in Kind.
∞ Member of the Partners for Innovation, Discovery and Health Society

Andrew and Michelle Feinberg

First Tennessee Bank
In honor of David Goldman

Foundation for Advanced Education
in the Sciences 2

Friends of Cancer Research 6

Estate of Jack Gramlich 5

Grifols Therapeutics 4

Hill-Rom

Rose J. Lem ∞

Freda C. Lewis-Hall, M.D., FAPA 3

Douglas R. Lowy, M.D.

Lumos Labs, Inc.

Steve and Sherry Mayer 3 ∞

Melinta Therapeutics 2

Myriad RBM 3

Neurotrack Technologies 2

Bob and Sally Newcomb 5

Pacific Biosciences

Robert E. Roberts, Ph.D. 7

Dame Jillian Sackler 13

Mrs. Lily Safra 14

Gerald R. Sigal and
Ellen V. Sigal, Ph.D. 6

Nina K. Solarz 6

University Hospitals Health System
In honor of Douglas Lowy

The Richard H. Yearick Foundation ∞

$5,000–$9,999

Anonymous (2)

Alzheimer’s Association® 11

Alzheimer’s Drug

Discovery Foundation 3

American Diabetes Association 6

American Heart

Association, Inc.

American Society for Clinical Pharmacology
and Therapeutics

The Association for Frontotemporal Degeneration

Basilea Pharmaceutica International Ltd. 5

Booz Allen Hamilton Inc.

Luther W. Brady, M.D.
In honor of Charles A. Sanders

Frank C. and Marcia M. Carlucci

The Coca-Cola Company 8 ∞

Ernesto I. Freire, Ph.D. and
Maria C. Freire, Ph.D. 4

Theodore N. Giovanis, M.B.A. ∞

Carol-Ann Harris 3

Susan C. Horowitz 4 ∞
In memory of Arthur G. Horowitz

James W. Jones 2
In memory of Brenda S. Jones

Jeffrey M. Leiden, M.D., Ph.D. and Lisa Leiden

Anne H. McMahon

The Multiple Myeloma Research Foundation

Proof Centre of Excellence Radiological Society
of North America 7

Matthew Scher and Barbara Lazio 3
In memory of Barbara L. Lazio and Carol Scher

Sigma Theta Tau International

Samuel O. Thier, M.D. and Paula Thier 10

Transmar Commodity Group LTD

Elias A. Zerhouni, M.D. and
Nadia Zerhouni, M.D. 3 ∞

$500–$4,999

$2,500–$4,999

Anonymous

Ronald and Barbara Berke 6
In memory of Jenny Berke

Joseph M. Feczko, M.D.
and Leighton K. Gleicher 8

Fisher Foundation

Paul J. Gattini 4

Happy Family Brands *

Chris and Laura C. Hazzard 7
In memory of Richard Curtin

Jed Herrmann

Gary G. Kochersberger, M.D. ∞

Kelly and Adam Leight 3

Mr. Mehdi Nafissi and
Dr. Ann F. Welton 8 ∞

Donna Nichols 6
In memory of Jay Nichols

Oncology Nursing Society

Matt and Robyn

Nichols Painter 5
In memory of Jay Nichols

Margot L. Pritzker

PTA Jankowski Charitable Fund

Sunny Raspet 3

John and Katrina Rogers 2
In memory of Brenda S. Jones

SunTrust Banks, Inc. 5 ∞

Christopher and
Elizabeth Thoma 2 ∞
In memory of Oberon Christopher Thoma

Travelers Companies, Inc.
In memory of Jared Latigona

Ullmann Family Foundation 7 ∞

Steve and Chris Wilsey 7

$1,000–$2,499

Anonymous (3)

AcademyHealth 2

Advanced Medical Technology
Association—AdvaMed

Daniel C. and Beverly Arnold

Dr. Nadarajah Balasubramanian 2 ∞

Bank of America Matching Gifts Program

Julie Bell Lindsay ∞
In memory of T. Douglas Lindsay

Ann L. Bell
In memory of T. Douglas Lindsay

Joe Bergera and Alice S. Cho 3 ∞

Wayne and Lea Berman 2

Zachary T. Bloomgarden, Ph.D. and
Kathy F. Bloomgarden, Ph.D. 7

Booster 2

Christopher J. Boyd and Jamie N. Cooper ∞
In memory of Sara Elizabeth Cooper

W. J. Boyle
In memory of Jared Latigona

Charles Cerf and Cynthia E. Dunbar, M.D. 5 ∞

City of Hope

Ellen Cramer

Crowell & Moring LLP

Daniel Cunningham and Mary Hennessey 2

Daniels Family Fund ∞
In memory of Ida Kirstein Gruzen

Rob and Betsey Drucker 4 ∞

Emergent BioSolutions, Inc.

F5 Networks 2 ∞

Rich Fachet
In memory of Jared Latigona

James M. Felser, M.D. 6

Mark Fernandez
In memory of Jared Latigona

William and Sherry Fiorani ∞
In memory of Oberon Christopher Thoma

Antonio T. Fojo, M.D. and Susan E. Bates, M.D.

James and Karen Gavic 6 ∞

Stanley and Eve Geller 10
In memory of Norman P. Salzman

Peggy J. Gerlacher 18
In memory of John D. Gerlacher

Eli Glatstein, M.D. 12 ∞

Margaret Grieve 3 ∞
In honor of Nina K. Solarz

Gary and Lynn Grossman 5

[x] Superscript indicates number of years of consecutive giving.
* Indicates Gifts in Kind.
∞ Member of the Partners for Innovation, Discovery and Health Society

David N. E. Heath
In memory of Jared Latigona

Paul Herrling, Ph.D. 2 ∞

Eric Hirschhorn and Leah Wortham 5
In honor of Nina K. Solarz

IQ Solutions 6

Jen Family Charitable Trust

Thomas Kenan

Kevin and Teresa Klock ∞
In memory of Fred E. Balding

Jeremy Krasner 4 ∞

Lafayette 89
In memory of Ewen Raballand

Gail Leese ∞

Howard H. and Jacqueline K. Levine 5

Jonathan D. Levine 5
In memory of Stephen J. Solarz

National League for Nursing

Omega World Travel Inc.

Matthew W. O’Neill and Erica Joyce Lam 7

Ankur Pandya
In memory of Jared Latigona

Lisa Paul
In memory of Jared Latigona

Michael and Melissa Phillips
In memory of Jared Latigona

Natalie Pyon

RBC Capital Markets, LLC

Emily Rehwinkel
In memory of Jared Latigona

Johng S. Rhim, M.D. and Mary L. Rhim 4 ∞

Gregory and Sherry Roper 2

Robert and Marjorie Rosenberg 5 ∞

Stanley O. Roth 2

The San Diego Foundation ∞

Cyrena Simons 2 ∞

Richard I. and Anastasia Smith 3 ∞

The Drs. Tremoulet 7

Jon and Kristin Vaver 8 ∞

Arthur L. and Lily D. Walters ∞

Michael and Lisa Nichols Whitten
In memory of Jay Nichols

Stewart K. Wilson 4 ∞
In memory of Blaise Ribet

Richard G. Wyatt, M.D. and
Linda S. Wyatt, Ph.D. 2

Lucas and Katrina Yun-Nikolac 2 ∞

$500–$999

Anonymous (3)

Dr. and Mrs. Robert B. Allison
In honor of Charles A. Sanders

James E. Balow, M.D. and Mary G. Balow 2
In honor of Kim Balow

Robert Barlow
In memory of Jared Latigona

Romit Bhattacharya ∞

Allen Morris and Barbara Bissell
In memory of Lisa Marie deCarbonel

Tino and Dawn Calabia 2

Megan Camillo
In memory of Jared Latigona

Dan Balliet and Jan Carlson 7 ∞

Michael and Melissa Cather 2 ∞

Jeffrey Chow 2

Madison Cox

Laura E. Crotty Alexander, M.D.

Eugene J. Dionne and Mary T. Boyle

Garth M. Eddy 2

Nicholas M. and Jacqueline E. Ferriter 2

Richard Folkers ∞

Seth P. Forster 2 ∞

Marie Francis
In memory of Jared Latigona

Martin Friedlander, M.D. and Sheila F. Friedlander, M.D. 2 ∞

Aaron Gibson 1 ∞

Guy Glazier
In memory of Ewen Raballand

Gene and Esther Gorman

Sam D. Graham, M.D. and Jane O. Graham 5 ∞

Mary Greer ∞
In memory of Thomas E. Barber

Ken and Yvette Guidry 9 ∞

Martin Hart ∞

Eric J. and Susan Hatch 2

Amy W. Hawthorne 3
In memory of Stephen J. Solarz

David and Carolyn Hobson ∞

Eva C. Holtz 6 ∞

James Howe, M.D.

Harold Huston ∞
In honor of Laura Huston

International Society of Nurses in Genetics

Charles E. Kaufman

Medical Fund 4

Kevin Kenworthy ∞
In memory of Thomas E. Barber

Robert A. and Bonnie A. Kotz

Ronald L. Krall, M.D. and Susan J. Krall 4 ∞

Colleen Kutner
In memory of Jared Latigona

Arnold Lakind ∞

John Langford 3 ∞

Arlene Latigona
In memory of Jared Latigona

Michael and Maria Lewan

Deborrah Lindsay ∞
In memory of T. Douglas Lindsay

Juan Liriano and

Genoveffa Caruso
In memory of Jared Latigona

Edison T. Liu, M.D., Ph.D. and Margaret B. Liu 3

Thomas A. and Nancy I. Lusk 2

John Madden, Jr. 3

Cathleen Martin 3

John and Stacy Martin 3 ∞

Kenneth V. McGinity

Robert and Margaret McNamara Foundation 2

Kristen Miller
In memory of Michele A. Shervin

Lloyd B. Minor, M.D.

Bayard H. Morrison, III, M.D. ∞

Reverend and Mrs. Robert H. Naylor

Gerald and Elizabeth Nissen 7
In honor of Matthew W. O’Neill and Erica Lam

Gilbert S. Omenn, M.D., Ph.D.
and Martha A. Darling 5 ∞

Andrew Park

PDC Machines
In memory of Robert Medl

Blair Puscas
In memory of Jared Latigona

Research!America

Kristin Roger
In memory of Jared Latigona

Jon and Patricia Rohal

Thomas and Susan Ross

Howard K. Schachman, Ph.D. 11
In memory of Ethel L. Schachman

Heidi M. Schambra, M.D.

Linda B. Schilling ∞
In memory of Mrunal S. Chapekar

Michael J. Shervin
In memory of Michele A. Shervin

Marielle Soboti
In memory of Jared Latigona

SOHO Publishing Company 4

Rainer F. Storb, M.D. 2 ∞

Donald Thompson 2 ∞

William and Zani Tolentino 7 ∞

Bryan J. Traughber, M.D.

Donald H. and Janet K. Trombley
In memory of Jared Latigona

Julie A. Tune 5 ∞
In memory of Gene Lasecki

Beth Turetsky, Ph.D.
In honor of Nina K. Solarz

Michael and Marianne Walter 2 ∞

Paula J. Warrick, Ph.D. 4 ∞

Robert C. Watson and Debra D. Petersen 5 ∞
In memory of Hayley Watson

Gail G. Weinmann, M.D. 4 ∞

Matthew Zimmerman ∞

$250–$499

$250–$499

Anonymous (7)

Essmaeel H. Abdel-Dayem, M.D.

Amazon Smile Foundation 2

Bruce J. Averbrook, M.D. 6

Neil Baluck
In memory of Michael Baluck

Paul Baluck
In memory of Michael Baluck

Jill H. Barr 7
In memory of John L. Barr

Joan Beck 5

Patricia Bernasconi
In memory of Jared Latigona

Jon H. Beusen and Denise D. Beusen, Ph.D. 2
In memory of Robert Ness

Ronald Borys
In memory of Jared Latigona

Anne Brockmeyer

William and Marcella Broocke
In memory of Ewen Raballand

Richard H. Carmona, M.D., MPH, FACS

Daniel Carucci, M.D., M.Sc., Ph.D. 6

Aileen Chen
In honor of Matthew W. O’Neill

Weiping Chen, Ph.D.

Joshua G. Cohen, M.D. and Jaclyn Cohen

Rochelle Cohen
In memory of Rex Sexton

Edward G. Conture, Ph.D. 3

Sanford Crystal
In memory of Jared Latigona

Louis D’Agostino
In memory of Jared Latigona

Daughters Of Penelope Hermione—Chapter 11

Michael Devine
In memory of Jared Latigona

Jeffrey J. Doenges

Taylor Draim

Ronald Early

Empire Kosher Poultry
In memory of Paul J. Albert

Shauna Ensrud 2

Michael Erickson

Jeffrey Fager

Gabriel B. Fosu, Ph.D.

Michelle Gaines
In memory of Jared Latigona

Jason and Gloria Garver 9

Rishi Goel 2

[x] Superscript indicates number of years of consecutive giving.
* Indicates Gifts in Kind.
∞ Member of the Partners for Innovation, Discovery and Health Society

Michael Gottlieb, Ph.D. and Joan Gottlieb 2

Lisa Green, M.D.

Keir Gumbs
In memory of T. Douglas Lindsay

Parker and Kiki Gundersen 2
In memory of Dean R. O’Neill

Gene Gutman, D.M.D. and Loren Gutman
In memory of Robert Medl

Robert Heady 3

Health Advances, LLC

James Horton, M.D. 2

Stephanie L. James, Ph.D. 5

Richard Jonas and Katherine Vernot-Jonas 8

Samantha Kaplan 3
In memory of Lizette Morazzani

Jared and Andrea Kaye

John Kennedy 6

Jody Kris

Melissa Kuskin 6
In memory of Bennett Camhi

Porcia B. Love, M.D.

Judith MacKay
In memory of Thomas E. Barber

Anne Alexander Marshall, Ph.D. and
Davis Marshall 11

Kevin Martin

Brian A. and Connie S. Mattingly

Larry R. and Anne R. McDowell
In memory of Jared Latigona

Ketan Mehta

Charles Mellody

Ari and Abbey Meltzer

Roger A. and Barbara Michaels 6

Judith Miller 2

Dean J. and Christine Montelbano
In memory of Jared Latigona

Jorge Morazzani 2
In memory of Lizette Morazzani

Ellen J. Nissen
In honor of Matthew W. O’Neill and Erica Lam

John and L. Susan Nissen

OAS Lunch Group
In memory of Monique H. Granado

Martin and Heather Oppenheimer
In memory of Arthur G. Horowitz

Kermit J. and Dorothy W. Osborne
In memory of Janice Weymouth

Sigmona Park
In memory of Thomas E. Barber

Robert Petterson

Martha Price 3
In memory of Jennifer R. Price

William J. Price 6

Sharon Raksnis
In memory of Jared Latigona

Carole Rawson

The Relias Family

Yasmin A. Rheubottom Morch

James and Lora Rodenberg 6
In honor of Dr. Lonser

Walter G. Rostykus and
Catherine Elliott-Rostykus 2

Dr. Michael Ryan and Dr. Linda Ryan 3

Lawrence E. Samelson, M.D.

Barbara Santos 2

Mansi Sarihan, M.D.

Nicole Schoeni-Toye
In honor of Matthew W. O’Neill
and Erica Lam

Michelle Schumaker

John G. Setter

Jill Small
In memory of Jared Latigona

Alan D. Sofranko, M.D. and
Caitlin M. Sofranko
In memory of Albert D. Sofranko

Russell W. Steenberg and Patricia Colbert 3

Bonnie S. Stein
In memory of Jared Latigona

Matt Stillinger
In memory of T. Douglas Lindsay

Suresh and Feroza Subramani 2

Anthony Tassone 3

Ryan Temming 3

Hughes Turner

Arlene Urquhart 5

Richard and Tracy Nichols Waggoner
In memory of Jay Nichols

Dr. and Mrs. Roy Weiner 2

Kenneth W. and Susan J. Weinstein

Westland Middle School
In memory of Ewen Raballand

Sara Lou Whildin 3

Ingrid Wiley 7

Julie and Howard Wolf-Rodda 9

Steven Wong 3

Robert Q. Wyckoff and
Alicia A. Longobardo
In memory of Shelby B. Reinish

Joyce A. Yarington 12
In memory of Martha Maddox

Joel Yesley 8

PARTNERS

PARTNERS SOCIETY

The Foundation for the NIH acknowledges individuals who have supported our programs with a major gift in 2015 as members of the Partners Society.

VISIONARY
(Gifts of $50,000+)

Buffy Cafritz

Mr. and Mrs. Joel S. Marcus

TRAILBLAZER
(Gifts of $25,000 – $49,999)

Mr. and Mrs. Paul M. Montrone

PIONEER
(Gifts of $10,000 – $24,999)

Rose J. Lem

Steve and Sherry Mayer

The Richard H. Yearick Foundation

INVESTIGATOR
(Gifts of $5,000 – $9,999)

The Coca-Cola Company

Ernesto I. Freire, Ph.D. and
Maria C. Freire, Ph.D.

Theodore N. Giovanis, M.B.A.

Susan C. Horowitz

In memory of Arthur G. Horowitz

Elias A. Zerhouni, M.D. and
Nadia Zerhouni, M.D.

EXPLORER
(Gifts of $1,000 – $4,999)

Anonymous (4)

Dr. Nadarajah Balasubramanian

Julie Bell Lindsay
In memory of T. Douglas Lindsay

Joe Bergera and Alice S. Cho

Christopher J. Boyd and
Jamie N. Cooper

In memory of Sara Elizabeth Cooper

Charles Cerf and 
Cynthia E. Dunbar, M.D.

Daniels Family Fund

In memory of Ida Kirstein Gruzen

Rob and Betsey Drucker

F5 Networks

William and Sherry Fiorani
In memory of Oberon Christopher Thoma

James and Karen Gavic

Eli Glatstein, M.D.

Margaret Grieve

In honor of Nina K. Solarz

Paul Herrling, Ph.D.

Kevin and Teresa Klock

In memory of Fred E. Balding

Gary G. Kochersberger, M.D.

Jeremy Krasner

Gail Leese

Mr. Mehdi Nafissi and
Dr. Ann F. Welton

Johng S. Rhim, M.D. and
Mary L. Rhim

Robert and Marjorie Rosenberg

The San Diego Foundation

Cyrena Simons

Richard I. and Anastasia Smith

SunTrust Banks, Inc.

Christopher and Elizabeth Thoma

In memory of Oberon Christopher Thoma

Ullmann Family Foundation

Jon and Kristin Vaver

Arthur L. and Lily D. Walters

Stewart K. Wilson
In memory of Blaise Ribet

Lucas and Katrina Yun-Nikolac

FELLOW
(Gifts of $500 – $999)

Anonymous (3)

Romit Bhattacharya

Dan Balliet and Jan Carlson

Michael and Melissa Cather

Richard Folkers

Seth P. Forster

Martin Friedlander, M.D.
and 
Sheila F. Friedlander, M.D.

Aaron Gibson

Sam D. Graham, M.D.
and 
Jane O. Graham

Mary Greer

In memory of Thomas E. Barber

Ken and Yvette Guidry

Martin Hart

David and Carolyn Hobson

Eva C. Holtz

Harold Huston
In honor of Laura Huston

Kevin Kenworthy
In memory of Thomas E. Barber

Ronald L. Krall, M.D.
and 
Susan J. Krall

Arnold Lakind

John Langford

Deborrah Lindsay
In memory of T. Douglas Lindsay

John and Stacy Martin

Bayard H. Morrison, III, M.D.

Gilbert S. Omenn, M.D., Ph.D. and
Martha A. Darling

Linda B. Schilling
In memory of Mrunal S. Chapekar

Rainer F. Storb, M.D.

Donald Thompson

William and Zani Tolentino

Julie A. Tune

In memory of Gene Lasecki

Michael and Marianne Walter

Paula J. Warrick, Ph.D.

Robert C. Watson and
Debra D. Petersen

In memory of Hayley Watson

Gail G. Weinmann, M.D.

Matthew Zimmerman

HONORARIUM GIFTS

You can honor a friend or family member for an important occasion with a gift to the FNIH. It is a wonderful way to send good wishes for a birthday or anniversary, thanks to a friend or doctor, or congratulations for retirement, a job well done or graduation. Please include the name and address of the individual being honored so that acknowledgement of your donation can be sent. In 2015, the FNIH received gifts in honor of the following individuals:

James Balow

Jeff Balow

Jill Balow

Kim Balow

Mary G. Balow

James Joseph Conley

Garth M. Eddy

Maria C. Freire, Ph.D.

Reva Gajer

Ernest Garcia

Jen Goff

Riley Goff

Travis Goff

David Goldman, M.D.

Randy Grossman

Kathleen Haley

Mark Hallett, M.D.

Christopher Heery, M.D.

Mike HelmsLaura Huston

Gail Jacobson

Alvin Kinsel

Mary Kinsel

Robert J. Kreitman, M.D.

Kathleen P. Krisko

Erica J. Lam

Marisa Leonard

Alison Linsley

Russell R. Lonser, M.D.

Douglas R. Lowy, M.D.

Michael McGinty

Patrick Mellody

Jessica Mosher

Brian R. O’Neill

Matthew W. O’Neill

Kristen S. Roach

Ann E. Sanders

Charles A. Sanders, M.D.

Jane M. Sayer, Ph.D.

Christine Sidelko Titley

David Simmons

Jean Simmons

Ellen Sirlin

Roger Sirlin

Nina K. Solarz

Ashleigh Stoddart

Steve Winkeler

Stuart H. Yuspa, M.D.

MEMORIAL GIFTS

Contributions are given to the FNIH at the request of family members in memory of loved ones. These generous contributions enhance our ability to support the NIH in its mission to improve health, by forming and facilitating public-private partnerships for biomedical research, education and training. We extend our sympathies to the family and friends of those memorialized below.

Paul J. Albert

Andrew J. Allison

Donald E. Andrews

Charles C. Azu, M.D.

Fred E. Balding

Michael Baluck

Thomas E. Barber

John L. Barr, M.D.

Karol Bell

Jenny Berke

William McCormick Blair

Laura Bodenheimer

Stephanie Guadalupe Burwinkel Coronado

Bennett Camhi

Laurie Carroll

Veronica S. Cassell

Mrunal S. Chapekar, Ph.D.

Colin Chignell, Ph.D.

Betty Coates

Jill Coe

Sara Elizabeth Cooper

Robert B. Cox

Richard Curtin

Jill Dansereau

Stella Davis

Lisa Marie deCarbonel

Daniel F. DeRusso

Eddie Dolegowski

Penny F. Dunker-Polek

Jean A. Dunn

Robert Enders

Margaret B. Fager

David M. Feit, M.D.

John D. Gerlacher

Zachary S. Glessner

Monique H. Granado

Gerald Graze

Ida Kirstein Gruzen

Kelly M. Harty

Mary C. Hennick

Annalise Marie Hoard

Gary D. Hodgen, Ph.D.

Arthur G. Horowitz

Marian F. Hughes

Ross Jacobs

Brenda S. Jones

Aelee Kim

Mabel Krendl

Wesley J. LaPorte

Dean W. Larson, M.D.

Gene Lasecki

Jared Latigona

Barbara L. Lazio

Erik J. Lemoine

T. Douglas Lindsay

Libby Link

Martha Maddox

Burton Maxwell

Karyn Michelle McCaslin

James T. McQueen

Robert Medl

John N. Miller

Lizette Morazzani

Stan C. Nebinski

Robert Ness

Jay Nichols

Dean R. O’Neill

Nancy Pannoni

Ellie Marie Phillips

Robert Pickett

Jennifer R. Price

Ewen Raballand

Shelby B. Reinish

Lindsey Powell Reusch

Blaise Ribet

Mary Richards

Linda Rozzelle

Kathleen Rudis

Norman P. Salzman, Ph.D.

Carlos Santos

Ethel L. Schachman

Neil Scharaga

Arthur G. Schatzkin, M.D., Ph.D.

Rex Sexton

Jillian D. Share-Johnson

Michele A. Shervin

Jefferson Sims, D.M.D.

Henry Sloane

Sarah Sloane

J. D. Smith

Albert D. Sofranko

Stephen J. Solarz

Emily Stevens

James Louis Stewart

Oberon Christopher Thoma

Peter J. Todd, Ph.D.

Paul Toole

Barry Allen Tubbs

Donald Tyler

Margaret Van Gelder

Lisa J. Wagner

Ronald T. Ware

Hayley Watson

McKenzie J. Wefler

Janice Weymouth

William A. Whiteside

Anne Wilson

Louise Wolf

Gary Wunderlich

William J. Yates

Robert A. Zanton

LEGACY SOCIETY

The Legacy Society recognizes individuals who have informed us that they have named the FNIH as a beneficiary in their will or estate plan. These legacy gifts can support a specific NIH program, area of research or other identified need, or they may provide unrestricted support to the FNIH. We thank the following individuals who have named the FNIH as a beneficiary.

Anonymous (4)

Judy Belous

The Honorable and Mrs. William
McCormick Blair, Jr.

Estate of William R. Boyle

Paula L. and William C. Bradley

William and Buffy Cafritz

Michael Davis

Estate of Sallie Rosen Kaplan

Marjorie D. Fuller

Estate of Jonathan D. Gest

Estate of Charles Harris

Kenneth M. and Patricia S. Kohlen

Zell Kravinsky, Ph.D. and
Emily Kravinsky, M.D.

Estate of Dorothy O. Newcomb

Patricia Nowosacki

Estate of Patrick M. O’Connor, Ph.D.

Estate of Dean R. O’Neill

Estate of Jennifer R. Price

Robert E. Roberts, Ph.D.

Estate of Frances H. Saupe

Jane M. Sayer, Ph.D.

Gail G. Thompson

Rita Visconte

Robert F. Wagner, Ph.D. and
Ellyn S. Wagner

Susan M. Wall, M.D.

Estate of Eugene Woolf and
Dismas S. Blanco

Funds & Endowments

We are grateful to the many individuals and organizations that have established funds or endowments at the FNIH to pay tribute to people and causes that matter to them. Such gifts provide essential ongoing support for research and education, as well as events in biomedicine at the NIH. Endowment gifts at all levels help to advance the pace of discovery and generate innovations that improve lives.

NAMED

Named funds are created to support specific areas of research or fellowships, lectures or awards at the NIH.

John I. and Elaine K. Gallin Fund
This fund has provided support for the Edmond J. Safra Family Lodge and continues to support patient and clinical research needs at the NIH.
Jayne Koskinas Ted Giovanis Foundation for Health Policy

Jayne Koskinas Ted Giovanis (JKTG) Foundation for Health and Policy provides funding for the intramural training and education of two deserving young scholars at the NIH during the 2015-2016 academic year.  Under the mentorship of Sharon Milgram, Ph.D., in the Office of Intramural Training and Education, one student will receive a NIH Postbaccalaureate Intramural Research Training Award/Cancer Research Training Award (Postbac IRTA/CRTA) with interest in nanotechnology and cancer therapeutics; the other, a scholarship to NIH’s Graduate Partnership Program (GPP) with research interest in mathematical/molecular modeling, brain circuitry and pain.

Roth Fellowship for CAEBV-HV Research
The Roth Fellowship fund was established to support a two year fellowship in the laboratory of Jeffrey I. Cohen, M.D., Chief of the Laboratory of Infectious Diseases and Chief of the Medical Virology Section at the National Institute of Allergy and Infectious Diseases (NIAID).  This fellow will conduct research to accelerate efforts in finding new drugs to treat Chronic Active Epstein Barr Virus (CAEBV) and Chronic Active Epstein Barr Virus-Hydroa Vacciniforme (HV) as well as understand genetic causes of the diseases that can lead to new treatments.

The Charles A. Sanders Legacy Fund
The creation of the Charles A. Sanders Legacy Fund will provide the flexibility for the FNIH to incubate new ideas and launch innovative, creative initiatives that will continue to enhance biomedical research. This investment will also allow the FNIH to maintain the operations structure to react rapidly and responsibly to new NIH requests under unique circumstances. Lastly, the fund will enable the FNIH to establish the Charles A. Sanders Partnership Award to recognize an outstanding, top-contributing industry partner each year.

Sayer Vision Research Lecture & Award
The Sayer Vision Research Fund, in collaboration with the National Eye Institute, supports an annual presentation delivered by an investigator conducting outstanding research in the area of vision research or related fields. The fund also provides the Sayer Vision Research Award, a grant to support the research of a promising independent investigator in the early stage of his or her career in the Division of Intramural Research whose work is closely related to aspects of vision research.K

Swanson Family Fellowship
The Swanson Family Fellowship supports research in TTF-1 Mutation Causing Benign Chorea in the laboratory of infectious diseases under the direction of Steven M. Holland, M.D., Chief of the Laboratory of Clinical Infectious Diseases at the National Institute of Allergy and Infectious Diseases at NIH.

MEMORIAL

Memorial funds create a living legacy. In many cases a family member may request that friends and relatives make donations—rather than send flowers—to support a chosen cause in memory of a loved one. Families may wish to make an investment in the FNIH by establishing a fund that embodies a loved one’s passion and spirit.

Dr. John L. Barr Memorial Fund
The Dr. John L. Barr Memorial Fund was established to support pain and palliative programs and cancer prevention and treatment. John L. Barr, M.D., was involved with both these fields as a doctor and a patient. The fund also supports the Intramural Research Training Award Fellowship Program at the NIH Clinical Center’s Pain and Palliative Care Program. The objective of the fellowship is to conduct research on pain and palliative care, and also to encourage young investigators to become more familiar with the importance of this field of study.

Adam J. Berry Memorial Fund
The Adam J. Berry Memorial Fund assists early career Australian scientists with travel between Australia and the United States to work at NIH. The Fund was established by Michael and Sue Berry to commemorate their beloved son Adam’s life and enthusiasm for research. Adam came from Australia to work as a research scientist at the National Cancer Institute.

The William N. Cafritz Trust
The William N. Cafritz Trust will be directed squarely at recruiting talented scientists and researchers to NIH studying in the field of Parkinson’s Disease.

John Laws Decker Memorial Fund
The Dr. John Laws Decker Memorial Fund honors the late John Laws Decker, M.D., who began working at the NIH in 1965 and had a long career there as Chief of Arthritis and Rheumatism Branch before serving as the NIH Clinical Center Director and Associate Director for Clinical Care from 1983 until his retirement in 1990. Dr. Decker was an outstanding teacher who strived to connect scientific communications around the world in an effort to accelerate important research. As part of the memorial, the NIH Fellows Committee nominates a presenter for the annual John Laws Decker Memorial Lecture at the Contemporary Clinical Medicine: Great Teachers Grand Rounds Program. This speaker also receives the Distinguished Clinical Teacher’s Award. The John Laws Decker Memorial Lecture is a fitting tribute to a recognized leader and teacher who was dedicated to education and to promoting research communication.

Jerry D. Jennings Memorial Fund
The Jerry D. Jennings Memorial Fund honors the father of Catherine Jennings Davis who died of renal cell cancer in July 2006.  The Jennings Family funds go to support renal cell cancer research at NIH.

Tracy’s Toy Box
Established by the family in memory of Tracy Nadel, this fund purchases toys and activities for children staying at the Edmond J. Safra Family Lodge. These items help make their time at the Family Lodge more comfortable and pleasant.

The Dr. Franklin A. Neva Memorial Fund
The Dr. Franklin A. Neva Memorial Fund honors the legacy of Franklin A. Neva, M.D., a renowned virologist, parasitologist, clinician and former director of the Laboratory of Parasitic Diseases (LPD) at the National Institute of Allergy and Infectious. The Fund supports an annual lecture on a topic related to clinical tropical medicine and associated pathophysiology as part of the LPD’s ongoing lecture series. It also supports an annual session held by the LPD and the Greater Washington Infectious Disease Society that is devoted to parasitic and/or tropical medicine, featuring discussions of individual cases.

Dean R. O’Neill Renal Cell Cancer
Research Fund
Founded in 2003, the Dean R. O’Neill Renal Cell Cancer Research Fund supports renal cell cancer research at the NIH. The most common form of kidney cancer, renal cell carcinoma is an under-researched and growing disease, with over 50,000 cases diagnosed each year.  The FNIH works closely with the O’Neill family to establish and continue a dedicated renal cell cancer research fellowship program in the laboratory of Richard Childs, M.D., Director of the National Heart, Lung, and Blood Institute.  The Fund supports two research fellowships — the Dean R. O’Neill Fellow and the Rancic-O’Neill Fellow — to explore new and existing treatments for renal cell cancer, such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy, and drug treatments.  Contributions to the Fund are provided by generous donors and the proceeds from the annual Boo! Run for Life 10K run and Tidal Basin walk in Washington DC each October.

Dr. Edward T. Rancic Memorial Fund
The Dr. Edward T. Rancic Memorial Fund provides support for a post-doctoral fellowship focused on renal cell cancer—the most common form of kidney cancer in the laboratory of Richard Childs, M.D., Director of the National Heart, Lung, and Blood Institute. The goal of this fund is to provide critical personnel support to accelerate the search for new breakthroughs in the treatment of kidney cancer with additional significant contributions received from individual donors. This fund is complementary to and in concert with the Dean R. O’Neill Renal Cell Cancer Research Fund and the Boo! Run for Life event.

Dr. Anita Roberts Memorial Fund
The Dr. Anita Roberts Memorial Fund awards travel scholarships for graduate students and post-doctoral fellows to present their work at a national meeting in honor of Anita Roberts, Ph.D., who was one of the first women laboratory chiefs at NIH and ranked in the top 50 most-cited biological scientists in the world. The Fund was established by the family and lab colleagues of Dr. Roberts. Widely recognized as an outstanding mentor for young scientists, Dr. Roberts had a passion for encouraging the career development of young scientists. These scholarships are a fitting tribute to Dr. Roberts’ commitment to mentoring.

Norman P. Salzman Memorial Award and Symposium in Virology
Norman P. Salzman, Ph.D.’s, family, colleagues and friends remember the legacy of this noted pioneer in molecular biology through contributions to this fund, which supports the annual Norman P. Salzman Memorial Award and Symposium in Virology. The half-day symposium addresses key topics in virology and immunology and presents an award to a young researcher, in recognition of Norman P. Salzman, Ph.D.’s mentorship of so many younger scientists.

Robert Whitney Newcomb Memorial Lecture and Internship
The Robert Whitney Newcomb Memorial Lecture and Internship was established by the family Robert W. Newcomb, Ph.D. who began his scientific career at NIH as a high school summer intern in a laboratory at the National Cancer Institute. The Fund endows an annual lecture by a recognized expert in neuroscience, selected by the National Institutes of Neurological Disorders and Stroke (NINDS). Honoring Dr. Newcomb’s own experience, it also provides for internships for high school students at NINDS.

Stephen J. Solarz Memorial Fund
Established in 2010, the Stephen J. Solarz Memorial Fund supports research in the laboratory of David Schrump, M.D. Chief of the Thoracic and Gastrointestinal Oncology Branch in the Center for Cancer Research of the National Cancer Institute.  In addition to overseeing thoracic surgery interventions for patients enrolled on NIH protocols, his research is designed to stimulate a patient’s immune system into fighting and preventing many different types of new cancer growth. Funds are used to support incredible talent by providing international fellowship opportunities to aspiring post-doctorate scientists and researchers in the field of cancer.

Stephen E. Straus Distinguished Lecture
The Stephen E. Straus Distinguished Lecture in the Science of Complementary Health Therapies was established in 2006 with a generous gift from Bernard and Barbro Osher. The annual address, given by leading figures in science and medicine who come to NIH to speak from their perspective about the field of complementary and integrative medicine, honors Stephen E. Straus, M.D., who was the founding director of NIH’s National Center for Complementary and Integrative Health.

ENDOWMENTS

Through these endowment gifts, donors ensure perpetual support for a variety of research and educational initiatives at the FNIH. The annual investment income generated by an endowment fund supports program expenses, while the principal remains intact to ensure future funding.

CarMollNat Muscular Dystrophy Endowment
Established by Carol-Ann Harris in honor of her family, the CarMollNat Muscular Dystrophy Endowment provides support for Muscular Dystrophy research at the Neurogenetics Branch of the National Institute of Neurological Disorders and Stroke.

Edna Williams Curl and Myron R. Curl Fund for Multiple Sclerosis Research
Established in 2007, this fund supports multiple sclerosis research at NIH.

Gramlich Melanoma Research Fund
This fund supports melanoma research at the NIH through an annual gift provided by the Jack Gramlich Foundation.

Sallie Rosen Kaplan Fund for Women Scientists in Cancer Research
The Sallie Rosen Kaplan Fund for Women Scientists in Cancer Research provides annual post-doctoral fellowship awards for outstanding woman scientists at the National Cancer Institute. Underrepresented minorities are encouraged to apply to this unique initiative. The goal of the Fellowship is to strengthen women scientists’ leadership skills through workshops, seminars, mentoring, coaching and support from a community of peers to retain and to help transition these women to independent research careers.

Endowments in Support of the Edmond J. Safra Family Lodge
Through endowment gifts, donors ensure perpetual support to the Edmond J. Safra Family Lodge for its operations and for the continued comfort of its guests.

GlaxoSmithKline Endowment
The GlaxoSmithKline Endowment supports programs and activities for families staying at the Edmond J. Safra Family Lodge, including services that help residents stay in touch with employers and loved ones.

Harry and Jeanette Weinberg Endowment
The Weinberg Endowment supports Edmond J. Safra Family Lodge operations and maintenance, ensuring that guests are provided a comfortable home away from home for years to come.

Board of Directors & Our Staff

Open post
Board of Directors

Charles A. Sanders, M.D. (Chairman)
Retired Chairman and Chief Executive Officer,
Glaxo, Inc.

Mrs. William McCormick Blair, Jr. (Secretary)
Director Emeritus, Albert and Mary Lasker Foundation

Kathy Bloomgarden, Ph.D.
Chief Executive Officer, Ruder Finn, Inc.

Mrs. William (Buffy) N. Cafritz
Honorary Trustee, The John F. Kennedy
Center for the Performing Arts

James H. Donovan
Managing Director, Goldman Sachs & Company;
Adjunct Professor, University of Virginia;
Trustee, Dana-Farber Cancer Institute

Joseph Feczko, M.D.
Retired Senior Vice President and Chief
Medical Officer, Pfizer Inc

Maria C. Freire, Ph.D.
President and Executive Director,
Foundation for the National Institutes of Health

Paul L. Herrling, Ph.D.
Chairman, Novartis Institute
for Tropical Disease

Ronald L. Krall, M.D.
Former Senior Vice-President and
Chief Medical Officer, GlaxoSmithKline

Judy Lansing Kovler, Ph.D.
Director, Kovler Foundation and
Vice Chair of Sasha Bruce, Inc.

Freda C. Lewis-Hall, M.D., FAPA
Chief Medical Officer, Senior Vice
President, Pfizer Inc

Edison T. Liu, M.D., Ph.D.
President and CEO,
The Jackson Laboratory

Ann Lurie
President, Lurie Holdings;
President and Treasurer,
Ann and Robert H. Lurie Foundation

Joel S. Marcus
Chairman, Chief Executive Officer
and Founder, Alexandria Real
Estate Equities, Inc. and
Alexandria Venture Investments

INTRODUCING NEW BOARD MEMBERS —In May 2015, the FNIH unanimously elected two new directors of the Foundation. Russell W. Steenberg, is the founder and global head of BlackRock Private Equity Partners, with more than 32 years of experience in private equity investment. Judy Lansing Kovler, Ph.D., is a psychotherapist in private practice with more than 30 years of experience working as a consultant to government agencies, including the White House, State Department and Secret Service.

Steven C. Mayer (Treasurer)
Former Chief Executive Officer, CoGenesys, Inc.

Paul M. Montrone, Ph.D.
Chairman, Perspecta Trust

Martin J. Murphy, Jr., Ph.D. DMedSc, FAFSCO
Founding Chairman and Chief Executive Officer, AlphaMed Consulting, Inc.

Steven M. Paul, M.D.
President and Chief Executive Officer
at Voyager Therapeutics, Inc. and
Venture Partner at Third Rock Ventures

The Honorable John Edward Porter
(Vice Chairman for Policy)
Hogan Lovells US, LLP

Jillian Sackler, D.B.E.
President and Chief Executive Officer,
Dame Jillian & Dr. Arthur M. Sackler
Foundation for the Arts, Sciences
& Humanities

Lily Safra
Chairwoman, The Edmond J. Safra
Philanthropic Foundation

Ellen V. Sigal, Ph.D.
Chairperson, Friends of Cancer Research

Solomon H. Snyder, M.D.
(Vice Chairman for Science)
Distinguished Service Professor of
Neuroscience, Pharmacology & Psychiatry,
Solomon H. Snyder Department of
Neuroscience at Johns Hopkins University

Nina K. Solarz
Former Executive Director of
Peace Links and the Fund for Peace

Russell W. Steenberg
Global Head, BlackRock
Private Equity Partners

Samuel O. Thier, M.D.
Professor of Medicine and Health Care
Policy, Emeritus, Harvard Medical School;
Massachusetts General Hospital

Anne Wojcicki
Chief Executive Officer and Co-Founder,
23andMe

HONORARY DIRECTORS

Luther W. Brady, M.D.
Affiliate Faculty Member in the Department of Radiation Oncology at Drexel University; Former Chair of the Department of Radiation Oncology, MCP Hahnemann University

Patrick C. Walsh, M.D.
University Distinguished Service Professor, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions

DIRECTOR EMERITUS

Paul Berg, Ph.D.
Cahill Professor in Biochemistry (Emeritus),
Stanford University School of Medicine

Sherry Lansing
Founder and Chief Executive Officer,
The Sherry Lansing Foundation

EX-OFFICIO

Francis S. Collins, M.D., Ph.D.
Director, National Institutes of Health

Stephen Ostroff, M.D.
Acting Commissioner,
Food and Drug Administration

Our Staff

PRESIDENT AND EXECUTIVE
DIRECTOR’S OFFICE

Maria C. Freire, Ph.D.
President and Executive Director

Ann Ashby, M.B.A.
Deputy Executive Director

Andrea Baruchin, Ph.D.
Senior Advisor to the President

Erika Tarver
Senior Project Manager

Felicia Gray
Executive Assistant

OPERATIONS

Kevin A. Klock, J.D.
Director of Operations
Advisor to the President

Susan Powell, M.T.S.
Senior Grants Manager

Kathy Peterson
Operations Officer

Liz Johns
Executive Assistant

FINANCE

Julie Tune, C.P.A., C.F.E.
Chief Financial Officer

Eva Coyne, C.P.A. 
Controller

Cathy Martin, C.P.A.
Senior Accountant

Noemi Rodriguez
Staff Accountant

Peggy J. Gerlacher
Operations Associate

COMMUNICATIONS

Abbey Meltzer, M.P.S.
Director of Communications

Richard Folkers
Director of Communications

Kai Yee
Digital Administrator

MEETINGS & EVENTS

Jolie Mak, C.M.P.
Meetings and Events Manager

Jasmin Miles, C.M.P.
Senior Events Coordinator

Janelle Lewis
Meetings and Events Planner

Sarah Kay
Events Assistant

Dalia Travis
Events Assistant

ADVANCEMENT

Melissa Cather
Director of Advancement

Jamie Cooper, M.A.
Advancement Officer

Rob Drucker, J.D.
Advancement Officer

Laren Friedman, M.F.A.
Writer/Researcher

Cassandra Hoye
Advancement Assistant

DEVELOPMENT

Julie Wolf-Rodda, M.A.
Director of Development

Renee Bullion, M.P.A.
Development Officer

Meredith Donnelly
Development Officer

Dinetta Parrott
Development Officer

Will Tolentino
Development and
Communications Systems Officer

Anisa Sanghrajka
Development Assistant

Jillian Bante
Development Assistant

SCIENCE

Stephanie James, Ph.D.
Director of Science and Director,
Grand Challenges in Global Health

Michael Gottlieb, Ph.D.
Deputy Director of Science

Dennis Lang, Ph.D.
Senior Program Coordinator (Contractor)

Karen H. Tountas, Ph.D.
Scientific Program Manager

Susan Wiener, M.A.
Senior Project Manager,
Grand Challenges in Global Health

David Brown, Ph.D.
Scientific Program Manager, CTC-VIMC

Gail Levine, M.A., C.R.C.C.
Scientific Program Manager, CTC-VIMC

Tiffany Francis
Executive Assistant
Contract Specialist

RESEARCH PARTNERSHIPS

David Wholley, M.Phil.
Director of Research Partnerships

Maria Vassileva, Ph.D.
Senior Scientific Program Manager, Metabolic Disorders

Paula Eason, Ph.D.
Scientific Program Manager, Cancer

Steven C. Hoffmann, M.S.
Scientific Program Manager,
Inflammation and Immunity

Rosa Canet-Aviles, Ph.D.
Scientific Program Manager, Neuroscience

Sanya Whitaker, Ph.D., P.M.P.
Scientific Program Manager,
Metabolic Disorders

Ron Benjamin, Pharm B, M.B.A.
Clinical Operations Manager

Jessica Ratay, M.S.
Clinical Project Manager

Dorothy Jones-Davis, Ph.D.
Scientific Project Manager, Neuroscience

Nicole Spear, M.A.
Scientific Project Manager

Cheryl Melencio
Executive Assistant

Jessica Jones
Administrative Assistant

INTERNS

Samantha Gonzales

Amber Langway

Celia Rumbin